Moderna (MRNA) has had the highest return since March 27, 2026 by a large-cap US stock, returning 301.1%.
| ASSET | % RETURN |
|---|---|
Moderna (MRNA) | 301.09% |
10X Genomics (TXG) | 274.64% |
Dell Technologies (DELL) | 230.9% |
Twist Bioscience (TWST) | 225.95% |
Corcept Therapeutics (CORT) | 218.17% |
Atlassian (TEAM) | 210.03% |
Okta (OKTA) | 197.81% |
Advanced Micro Devices (AMD) | 194.51% |
Astera Labs (ALAB) | 191.99% |
Oscar Health (OSCR) | 189.94% |
Hewlett Packard Enterprise (HPE) | 184.34% |
Crowdstrike (CRWD) | 183.68% |
Micron Technology (MU) | 175% |
Palo Alto Networks (PANW) | 173.69% |
Marvell Technology (MRVL) | 169.4% |
Rubrik (RBRK) | 156.6% |
United Microelectronics (UMC) | 154.4% |
Everpure (P) | 153.32% |
Humana (HUM) | 150.45% |
Sandisk (SNDK) | 147.99% |
Fortinet (FTNT) | 142.11% |
Datadog (DDOG) | 139.41% |
NetApp (NTAP) | 132.41% |
Intel (INTC) | 132.35% |
Unity Software (U) | 130.8% |
Large-cap stocks are treated as having a market cap of $10B+.